Cargando…
Lobaplatin for the treatment of SK-MES-1 lung squamous cell line in vitro and in vivo
Lung squamous cell carcinoma is the second-largest histological subtype of lung cancer, which is the leading cause of cancer-related death worldwide. Lobaplatin, one of the third-generation platinum compounds, has shown encouraging anticancer activity in a variety of tumors. The aim of this study wa...
Autores principales: | Zhang, Hongming, Chen, Runzhe, Yang, Shaoxing, Liu, Wenjing, Li, Ke, Zhang, Haijun, Zhu, Xiaoli, Chen, Baoan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4948715/ https://www.ncbi.nlm.nih.gov/pubmed/27471396 http://dx.doi.org/10.2147/OTT.S108032 |
Ejemplares similares
-
Lobaplatin-Induced Apoptosis Requires p53-Mediated p38MAPK Activation Through ROS Generation in Non-Small-Cell Lung Cancer
por: Zhang, Hongming, et al.
Publicado: (2019) -
Comparison of the therapeutic effects of lobaplatin and carboplatin on retinoblastoma in vitro and in vivo
por: Zhou, Zijun, et al.
Publicado: (2020) -
COVID-19 Transmission Within a Family Cluster in Yancheng, China
por: Zhang, Hongming, et al.
Publicado: (2020) -
Expression of the SARS-CoV-2 receptor ACE2 reveals the susceptibility of COVID-19 in non-small cell lung cancer
por: Zhang, Hongming, et al.
Publicado: (2020) -
Brentuximab vedotin for treatment of relapsed or refractory malignant lymphoma: results of a systematic review and meta-analysis of prospective studies
por: Chen, Runzhe, et al.
Publicado: (2015)